Technology to help fight infection for cardiac patients
PATIENTS receiving cardiac treatment at St Andrew's Toowoomba Hospital now have access to new technology for fighting off infection.
Called TYRX Absorbable Antibacterial Envelope, the product can be used by interventional cardiologists when inserting cardiovascular implantable devices, such as pacemakers or defibrillators.
The envelope holds the electronic implantable device and is designed to stabilise the device after implantation, while releasing two antibiotics over seven days to help reduce surgical-site infections.
According to Interventional Cardiologist Dr Harish Aikot: "Infections can be very debilitating for patients following surgery.
"While the risk of infection is low for most patients receiving an implantable device, the TYRX™ envelope offers an extra layer of protection and provides a solution which makes implantable device procedures safer for patients."
In Dr Aikot's opinion, "the technology is particularly useful for high-risk patients."
"High risk patients include those with diabetes, with a previous history of infection, patients having a revision or upgrade procedure, or patients with renal failure or congestive heart failure."